fda-inspection-records

Biologics: FDA inspections and Form 483 observations

8,735 firms with at least one Biologics inspection. Most serious classification on file: 5,174 NAI, 3,267 VAI, 294 OAI.

The 25 observations cited most often (Biologics program)

RegulationObservationTimes cited
21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs1,032
21 CFR 606.100(c)Thorough investigations340
21 CFR 606.160(a)(1)Concurrent documentation245
21 CFR 606.160(b)Required records245
21 CFR 606.171Biological product deviation report215
21 CFR 606.160(a)(1)Person performing, test results, interpretation205
21 CFR 606.60(a)Equipment observed, standardized, calibrated132
21 CFR 606.65(e)Following manufacturer's instructions124
21 CFR 606.20(b)Qualifications of responsible personnel97
21 CFR 606.160(a)(1)Legibility and indelibility81
21 CFR 606.60(b)Equipment calibration frequency79
21 CFR 606.100(c)Record review prior to release77
21 CFR 606.40(a)(1)Provide space for examination72
21 CFR 606.60(a)Maintain and clean equipment65
21 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration60
21 CFR 606.151(e)Procedures to maintain records of emergency transfusions59
21 CFR 606.170(a)Adverse Reaction - Investigations49
21 CFR 606.170(a)Adverse Reaction- Reports of Investigations49
21 CFR 640.3(a)(1)Donor suitability procedures not followed48
21 CFR 600.14(c)When to report44
21 CFR 640.4(f)Arm preparation41
21 CFR 600.10(b)Personnel capabilities41
21 CFR 630.40(a)Notification39
21 CFR 606.40Clean & orderly38
21 CFR 606.60(a)Provide proper equipment to meet requirements37

Frequencies of posted Form 483 citations, all fiscal years. They describe what investigators write most often, not any firm.

By state